New eye drops target seasonal allergy misery
NCT ID NCT06602739
Summary
This study tested whether two experimental drugs, REGN5713 and REGN5715, could safely reduce the signs and symptoms of allergic conjunctivitis (eye allergies) caused by birch pollen. Fifty-four adults with a confirmed birch pollen allergy participated. Researchers compared the effects of the drug combination to a placebo (an inactive substance) by measuring changes in eye itch, redness, and tearing after a controlled pollen exposure.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALLERGIC CONJUNCTIVITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Andover Eye Associates
Andover, Massachusetts, 01810, United States
-
Clinique de Specialisee en Allergie de la Capitale
Québec, G1V 4W2, Canada
-
Kingston Health Sciences Centre
Kingston, Ontario, K7L 2V7, Canada
Conditions
Explore the condition pages connected to this study.